Changes of Contrast Enhancement in Relation to Histologically Proven Malignant Progression
| Progression | Contrast enhancement neither at baseline nor at follow-up (no. of patients) | Contrast enhancement at baseline as well as at follow-up (no. of patients) | Newly appearing contrast enhancement at follow-up (no. of patients) |
| Patients with malignant progression (n = 18) | 3 | 7 | 8 |
| Patients without malignant progression (n = 9) | 4 | 5 | 0 |